Agreement for the distribution of medicinal and combinatorial chemistry technology which claims to speed chemical reactions by a factor of up to 1000 and improve yield
Personal Chemistry has announced that it has entered into an agreement with the Japanese subsidiary of Amersham Biosciences for the distribution of Coherent Synthesis, Personal Chemistry's complete solution for medicinal and combinatorial chemistry.
Amersham will be the sole distributor of Personal Chemistry's products in Japan.
Coherent Synthesis incorporates innovative chemistry methodology, software, automation, microwave technology and reagents to speed up chemical reactions by between ten and 1000 times, often with an increased yield of the compound.
In addition to the increased speed and yield, the technology may solve complex chemistry problems that were previously very difficult to undertake using traditional methods.
Emrys knowledge builder was launched in May and is a knowledge management system for Coherent Synthesis, combining reaction warehousing, search tools, reaction browsers, conversion of search results to executable experiments and post-synthesis data capture.
Scott Carr, vice president worldwide sales for Personal Chemistry, commented: "Amersham Biosciences is recognised as a leader in life science technology and supply and our partnership with them will provide instant visibility for our Coherent Synthesis technology in the Japanese market.
We have experienced dramatic sales growth in the USA and in Europe over the past 12 months and are excited to be launching our products in Japan." By adding Personal Chemistry's technology to its existing product lineup, Amersham aims to strengthen its existing product portfolio in the support of drug discovery at pharmaceutical companies and in academic research institutes.
As part of the first sale of Coherent Synthesis in Japan, Amersham will install Personal Chemistry's instrument at GlaxoSmithKline.
